Azzad Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95M Buy
9,403
+2
+0% +$1.12K 0.44% 68
2026
Q1
$5.28M Hold
9,401
0.53% 40
2025
Q4
$6.36M Buy
9,401
+1
+0% +$681 0.62% 23
2025
Q3
$6.01M Buy
9,400
+735
+8% +$446K 0.59% 30
2025
Q2
$4.65M Buy
8,665
+807
+10% +$386K 0.5% 41
2025
Q1
$3.3M Buy
7,858
+699
+10% +$304K 0.39% 79
2024
Q4
$2.96M Buy
7,159
+418
+6% +$183K 0.57% 49
2024
Q3
$3.41M Buy
6,741
+2,038
+43% +$990K 0.38% 82
2024
Q2
$2.29M Hold
4,703
0.27% 145
2024
Q1
$2.54M Buy
4,703
+307
+7% +$168K 0.3% 127
2023
Q4
$2.44M Sell
4,396
-8
-0.2% -$3.76K 0.31% 123
2023
Q3
$1.93M Buy
+4,404
New +$2.2M 0.27% 150
2022
Q4
Sell
-2,225
Closed -$729K 351
2022
Q3
$729K Buy
2,225
+36
+2% +$13.2K 0.07% 309
2022
Q2
$750K Buy
2,189
+1,700
+348% +$693K 0.07% 307
2022
Q1
$268K Buy
489
+5
+1% +$2.63K 0.04% 311
2021
Q4
$319K Sell
484
-17
-3% -$10.7K 0.04% 312
2021
Q3
$312K Sell
501
-195
-28% -$131K 0.05% 306
2021
Q2
$440K Buy
696
+19
+3% +$10.5K 0.07% 290
2021
Q1
$331K Buy
677
+29
+4% +$14.5K 0.05% 290
2020
Q4
$324K Sell
648
-6
-0.9% -$2.69K 0.06% 268
2020
Q3
$257K Sell
654
-226
-26% -$83.6K 0.05% 276
2020
Q2
$291K Buy
+880
New +$255K 0.07% 273
2020
Q1
Sell
-1,168
Closed -$366K 322
2019
Q4
$366K Hold
1,168
0.04% 325
2019
Q3
$369K Buy
+1,168
New +$325K 0.05% 320

Other funds holding IDXX

Azzad Asset Management's IDXX Position: Q2 2026 in Review

Azzad Asset Management increased its Idexx Laboratories (IDXX) stake by 0.02% in Q2 2026, buying an estimated $1.12K and bringing the position to 9,403 shares worth $4.95M. The position accounts for 0.44% of the portfolio, ranked #68.

Azzad Asset Management first reported a position in IDXX in Q3 2019 and has held it in 24 quarters since. The position peaked at $6.36M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Azzad Asset Management held 9,403 shares of Idexx Laboratories worth $4.95M as of Q2 2026.
  • Azzad Asset Management bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up 0.44% of Azzad Asset Management's portfolio in Q2 2026, its #68 holding.
  • Azzad Asset Management first reported a position in Idexx Laboratories in Q3 2019 and has held it in 24 quarters since.
  • Azzad Asset Management's Idexx Laboratories position peaked at $6.36M in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.